UVG has helped our clients secure over $625 million in government awards.
BARDA funds high-impact MCMs of national importance. BARDA also provides subject expertise to help advance MCMs, including regulatory and animal rule expertise.
BARDA offers a range of funding options for the development of medical countermeasures. In addition to the the combined BARDA BAA, BARDA's new DRIVe BAA offers early-stage support for specific subject areas.
BARDA is different from NIH and DoD, and UVG helps our clients navigate the differences. We support technical planning, budget development, project management, and more. For early stage startups, we also can help you engage DRIVe, BARDA's new innovation arm.
UVG has an unmatched track record of success with full proposals submitted to BARDA. We have guided clients in multiple medical device and therapeutic areas, including awarded contracts spanning nearly a decade. We have supported two successful OTAs.
Whether you are a multinational pharma or a brand-new startup, we have the resources and experience to help you successfully engage BARDA.